HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NUS

Nu Skin Enterprises, Inc. (NYSE)

Consumer Defensive — Household & Personal Products

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

None
$5.25
$-0.03 (-0.57%)
Sign in to add NUS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$254.89M
P/E Ratio (TTM)4.86
Forward P/E3.98
EPS (TTM)$1.08
Dividend Yield4.57%
Profit Margin3.78%
Revenue Growth-12.00%
ROE7.04%
Debt/Equity38.19
Recommendation None
Analyst Target-
Analysts-
Indexes NYSE

Technical Indicators

RSI (14)43.4
Beta0.95
SMA 20-
SMA 40-
52-Week High$14.62
52-Week Low$4.89
50-Day Avg$6.06
200-Day Avg$8.81
Avg Volume657.5K
Volume674.3K

Performance Analysis

NEUTRAL

NUS presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($4.89), which could present a value opportunity.
~ RSI at 43.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 4.9 suggests the stock may be undervalued.
- Revenue declined 12.0% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:23 UTC

Back to Screener Export Report